PharmaScroll’s Post

In a crowded pharmaceutical market, reaching the right healthcare professionals and promoting new medications effectively is crucial. Digilign's Fast Growth Package empowers pharmaceutical companies to drive brand awareness and physician engagement. We develop targeted advertising campaigns across various channels to connect with physicians specializing in relevant therapeutic areas. Leverage our AI technology to personalize messaging and content recommendations based on individual physician needs and prescribing habits. Create high-quality educational content (e.g., clinical trial results, case studies) that showcases the value proposition of your new medications. Develop ongoing engagement strategies to nurture relationships with key opinion leaders and ensure medication adherence among patients. Maximize the impact of your brand with Digilign by your side. #Pharmaceuticals #PhysicianMarketing #DigitalMarketing #AI #MedicalAffairs #PatientAdherence #Digilign

KOLs play a pivotal role in bridging the gap between pharmaceutical companies, healthcare providers, and patients, contributing to advancements in medical science, improved patient outcomes, and the responsible use of medications. PharmaScroll's TreasureTell database offers a comprehensive KOL analytics platform, providing clients with a wealth of data on KOLs in various therapy areas. It enables effective KOL identification, profiling, ranking, and network mapping while monitoring their activities and online presence. Learn More: https://lnkd.in/dFtbedKc #PharmaScroll #healthcare #pharmaceutical #digital #keyopinionleaders #treasuretell #socialmedia #engagement #research #insights #expertinsights #analytics

#NewPublication: 'Transformative Policies to Realise Universal Access to Medicines' https://lnkd.in/dNNkKgtW Our publication 📘 highlights the critical need for innovative, non-commercial approaches to pharmaceutical research, development and distribution. It advocates for knowledge sharing and public ownership to ensure that everyone, regardless of economic status, has access to essential medicines. 🌍 Our publication critically examines the limitations of profit-driven models in the pharmaceutical industry and proposes #OpenScience and public pharmaceutical institutions as viable solutions. This is a call to action for policymakers, #Healthcare professionals, and global #Health advocates to prioritise #HumanRights and #PublicHealth goals over commercial interests. It is a must-read for those dedicated to transforming healthcare access globally! 💡 #RightToHealth #HumanRights

🌟 Episode 2: Understanding Market Access in Pharma 🌟 In this new chapter, we dive into the concept of market access to establish a baseline understanding for everyone. 🔍 What is Market Access? In the pharmaceutical industry, market access involves ensuring that products—such as drugs, medical devices, and in vitro diagnostics—are available to patients. 📊 Key Activities in Market Access: 📌 Health Technology Assessment (HTA): Designing dossiers to demonstrate the product’s value. 📌 Pricing: Determining the right price that reflects the product’s value. 📌 Health Economics and Outcomes Research (HEOR): Generating evidence of economic and clinical value. 📌 Stakeholder Engagement: Building relationships with key stakeholders. 📌 Negotiations with Payers: Discussing coverage, reimbursement, and pricing. This episode also touches on the goal of market access strategies, which is to demonstrate the value of a drug to payers and other stakeholders. We’ll explore more about this in future episodes. Don’t forget to subscribe to my channel for more insights and updates. Until then, stay curious and tuned! #Pharma #MarketAccess #HealthcareSystems #Negotiations #HTA #HEOR #ValueBasedPricing #PatientAccess #Pricing

In today's 'HEOR Simplified' video, our MD Mehdi Javanbakht (Ph.D.) is answering the question "What should manufacturers consider regarding HEOR and Market Access after completing a phase 3 clinical trial?" If you'd like to discuss your case with us, feel free to book a no obligation call here: https://lnkd.in/e628phSJ #HEOR #reimbursement #costeffectiveness #pharmaceuticals #HTA #marketacces #HealthEconomics 

💻💊 #Axioma by #ProximaResearch has database of healthcare professionals (HCPs) and organizations (HCOs), which provides vital insights for targeted marketing strategies 👥 Key indicators like “patient flow” and “call pressure”: patient flow reveals the average number of patients seen by a doctor weekly, pinpointing those with significant prescribing influence, and call pressure indicates the frequency of visits from medical representatives 📊 Regularly updated data ensures timely access to the latest information, allowing for agile responses to market trends    📍 With targeted campaigns fueled by comprehensive insights, businesses can drive growth and success in the competitive pharmaceutical landscape   📲 Learn more via link: http://surl.li/symoc #pharmacy #pharmacieuticalmarket #database #data 

Today’s global health challenges require #digitalhealth solutions and constant innovative approaches. As new technologies impact every aspect of the #biopharmaceutical value chain, from drug discovery to clinical development, our industry is investing in digital health to enhance the contributions we make to patients and health systems around the world. We believe that digital health should create more effective, efficient, and patient-outcome-focused health systems. Our Global Principles on Digital Health, built with EFPIA - European Federation of Pharmaceutical Industries and Associations & #JPMA, guide our work: https://ifpma.info/3I4sqnS

News Alert: Recently FDA-Approved Drugs (Monthly Edition)! 📢 Hey there, health enthusiasts! Are you ready to stay up-to-date on the most recent medical breakthroughs? Say hello to our Monthly Edition of FDA-approved medications—your go-to resource for innovative therapies and game-changing medical advancements. 🚀 From innovative therapies to groundbreaking medications, we're diving deep into the world of pharmaceutical innovation, bringing you the scoop on what's new and noteworthy. Get ready to discover life-changing medications that could pave the way for a healthier future! Let us go on this exploration together, so stay tuned and informed. Because when it comes to our health, knowledge truly is power! 💊 . . . . . . #FDAApproved #PharmaRegulation #DrugApproval #ApprovedDrugs #DrugInnovation #DrugDevelopment #Pharmaceuticals #MedicalInnovation #medicine #medicalinnovation #healthcareindustry #TheLotusBiotech #tlb

𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮 𝗡𝗲𝘄 𝗗𝗿𝘂𝗴   In today's competitive pharmaceutical landscape, reaching the right audience with the right message is crucial.   Our latest video delves into how a top pharmaceutical company revolutionized clinical treatments across Europe with an innovative new drug.   Learn how Jasper Colin expertly navigated physician engagement, competitor analysis, and messaging strategies to achieve remarkable success.   Watch now to uncover the secrets behind this strategic triumph in medicine. Join us in exploring the power of precise positioning and tailored communication in shaping the future of healthcare. #JasperColin #DatatoDecision #Pharmaceuticals #ClinicalInnovation #StrategicPositioning #HealthcareMarketing #PharmaSuccess #DrugDevelopment #HealthcareStrategy #PharmaMarketing #InnovationInMedicine #KOLConsultations #PhysicianEngagementSurveys #CompetitorLandscapeMapping #TailoredMessagingWorkshops

Taiwan pharmaceutical market size is only less 1% of global pharmaceutical market, thus, Taiwan biotech company must enter global Market, otherwise the company growth will be very limited. So either Taiwan R&D or generics company must think about how to be player in the global market. And the first issue is market intelligence, which is one of weakness for Taiwan. Local market intelligence should include political and economic situation, healthcare policy, healthcare system, regulatory,medical and drug reimbursement schemes etc. So how to build up infrastructure and know how of international business development is a crucial and urgent item.